12 completed, 2 recruiting, 1 active not recruiting, 1 not yet recruiting. 8 Phase 2, 5 Not applicable, 4 Phase 3, 3 Phase 1, 1 Phase 4.
Follow Superficial Basal Cell Carcinoma: new trials by email Literature Review of Superficial Basal Cell Carcinoma trials Research Report on Superficial Basal Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| High Intensity Focused Ultrasound vs. Cryotherapy in the Treatment of Basal Cell Carcinomas and Bowen's Disease in Adults High Intensity Focused Ultrasound, Cryotherapy - Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma | Not applicable | Not yet recruiting | Jussi Salonen | 294 | 2026-04-01 | 2026-02-03 |
| Proof of Concept Study to Access Superficial Basal Cell Carcinoma in Adults Tirbanibulin Ointment 1% - Superficial Basal Cell Carcinoma | Phase 2 | Completed | Austin Institute for Clinical Research | 5 | 2023-04-17 | 2024-07-19 |
| 5-Fluorouracil and Calcipotriene for Treatment of Low Grade Skin Cancer Combination cream of 5-fluorouracil and calcipotriene, 5-fluorouracil cream - Superficial Basal Cell Carcinoma, Squamous Cell Carcinoma in Situ | Phase 2 / Phase 3 | Recruiting | Boston University | 200 | 2022-10-15 | 2025-11-28 |
| A Study to Evaluate the Safety and Efficacy of EscharEx (EX-02) in the Treatment of Basal Cell Carcinoma EscharEx 5% (EX-02 formulation) - Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma | Phase 1 / Phase 2 | Recruiting | MediWound Ltd | 32 | 2021-06-30 | 2021-12-15 |
| Optical Coherence Tomography Guided Laser Treatment of Basal Cell Carcinoma 1064 nm long-pulse Nd:YAG laser - Basal Cell Carcinoma, Superficial Basal Cell Carcinoma | Not applicable | Completed | Christopher Zachary | 29 | 2021-01-13 | 2026-10-21 |
| Use of Jet-injection in Photodynamic Therapy for Basal Cell Carcinoma Jet injection of ALA, Surgical excision, Illumination - BCC, BCC - Basal Cell Carcinoma | Phase 2 | Completed | Memorial Sloan Kettering Cancer Center | 16 | 2020-09-09 | 2026-06-18 |
| Safety and Efficacy Evaluation of AIV001 in Nonmelanoma Skin Cancer of the Low Risk Basal Cell Carcinoma Subtype AIV001, AIV001 suspension - Superficial Basal Cell Carcinoma, Nodular Basal Cell Carcinoma | Phase 1 / Phase 2 | Completed | AiViva BioPharma, Inc. | 26 | 2020-08-18 | 2024-12-27 |
| Study to Evaluate the Safety and Efficacy of BF-200 ALA (Ameluz®) and BF-RhodoLED® in the Treatment of Superficial Basal Cell Carcinoma (sBCC) With Photodynamic Therapy (PDT). Photodynamic therapy (PDT) (ALA-PDT, Ameluz®-PDT), Placebo Photodynamic therapy (PDT) (vehicle to BF-200 ALA containing no active ingredient) - Superficial Basal Cell Carcinoma | Phase 3 | Active not recruiting | Biofrontera Inc. | 187 | 2018-09-25 | 2026-01-14 |
| A Patient Decision Aid for Patients With Superficial Basal Cell Carcinoma Patient decision aid for patients with superficial basal cell carcinoma - Superficial Basal Cell Carcinoma | Completed | Maastricht University Medical Center | 222 | 2018-01-01 | 2022-11-29 | |
| Randomized Pilot Study of Treatment for BCC Using the Multiplex 595/1064 nm Laser 595/1064 multiplex laser - Nodular Basal Cell Carcinoma, Superficial Basal Cell Carcinoma | Not applicable | Completed | University of Miami | 12 | 2014-10-01 | 2018-10-02 |
| Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial full ablative CO2 laser, fractional ablative CO2 laser, MAL - Bowen's Disease, Superficial Basal Cell Carcinoma | Not applicable | Completed | University Hospital, Ghent | 16 | 2014-09-01 | 2018-01-25 |
| Superficial Basal Cell Carcinoma Treatment With Topical Photodynamic Therapy With Fractionated 5-aminolevulinic Acid 20% Versus Two Stage Methylaminolevulinate Methylaminolevulinate PDT in 2 sessions, Fractionated 5-aminolevulinic acid hydrochloride 20% gel PDT - Superficial Basal Cell Carcinoma | Phase 4 | Unknown | Maastricht University Medical Center | 162 | 2013-08-01 | 2014-01-31 |
| PEP005 Gel - Evaluation of the Safety and Efficacy of Ingenol Mebutate Gel on a Superficial Basal Cell Carcinoma on the Trunk or Extremities PEP005 (ingenol mebutate) Gel, 0.05%, Aluminium disk, OpSite(TM) disk - Superficial Basal Cell Carcinoma | Phase 2 | Completed | Peplin | 75 | 2011-04-01 | 2016-02-26 |
| Cure Rates of Superficial Basal Cell Carcinoma (BCC) EDC Electrodessication & Curettage - Superficial Basal Cell Carcinoma | Not applicable | Terminated | University of Wisconsin, Madison | 85 | 2008-05-01 | 2015-02-27 |
| Dose-Ranging Clinical Trial of Topical Creams Containing API 31510 for the Treatment of Superficial Basal Cell Carcinoma API 31510 3% Topical Cream, API 31510 1.5% Topical Cream, Placebo - Superficial Basal Cell Carcinoma | Phase 1 / Phase 2 | Completed | BPGbio | 186 | 2008-03-01 | 2025-02-28 |
| To Determine the Maximum Tolerated Dose Level (MTD) of PEP005 Topical Gel in Patients With sBCC PEP005 - Superficial Basal Cell Carcinoma | Phase 2 | Completed | Peplin | 117 | 2007-02-01 | 2016-02-15 |
| Open-label Study to Evaluate Clearance of Superficial Basal Cell Carcinoma After Use of Imiquimod 5% Cream Imiquimod 5% cream - Superficial Basal Cell Carcinoma | Phase 3 | Completed | Graceway Pharmaceuticals, LLC | 169 | 2001-03-01 | 2010-08-10 |
| Metvix Photodynamic Therapy (PDT) Versus Cryotherapy in Participants With Primary Superficial Basal Cell Carcinoma Metvix® cream, Hand held liquid nitrogen spray cryotherapy - Superficial Basal Cell Carcinoma | Phase 3 | Completed | Galderma R&D | 120 | 1999-10-18 | 2024-08-19 |
Carcinoma, Basal Cell (5) · Bowen's Disease (2) · Connective Tissue Diseases (1) · Neoplasms, Basal Cell (1) · Skin Diseases (1) · Squamous Intraepithelial Lesions (1)
Carcinoma (6) · Neoplasms (6) · Neoplasms by Histologic Type (6) · Neoplasms, Glandular and Epithelial (6) · Neoplasms, Basal Cell (4) · Carcinoma, Squamous Cell (2) · Neoplasms, Squamous Cell (2) · Morphological and Microscopic Findings (1) · Pathological Conditions, Signs and Symptoms (1) · Skin and Connective Tissue Diseases (1)
3-ingenyl angelate (2) · methyl 5-aminolevulinate (2) · 1-phenyl-3,3-dimethyltriazene (1) · Anesthesia, Local (1) · Cryotherapy (1) · Curettage (1) · Epinephrine (1) · Gels (1) · Imiquimod (1) · Infectious Disease Incubation Period (1) · Lidocaine (1) · Lighting (1) · Photochemotherapy (1) · calcipotriene (1) · tirbanibulin (1)
Maastricht University Medical Center (2) · Peplin (2) · AiViva BioPharma, Inc. (1) · Austin Institute for Clinical Research (1) · BPGbio (1) · Biofrontera Inc. (1) · Boston University (1) · Christopher Zachary (1) · Galderma R&D (1) · Graceway Pharmaceuticals, LLC (1) · Jussi Salonen (1) · MediWound Ltd (1) · Memorial Sloan Kettering Cancer Center (1) · University Hospital, Ghent (1) · University of Miami (1)
United States (11) · Australia (2) · Belgium (2) · Finland (2) · Netherlands (2) · Austria (1) · France (1) · Italy (1) · New Zealand (1) · Sweden (1) · United Kingdom (1)
Angela Smith (1) · Anthony Rossi, MD (1) · Barbara Boone, MD PhD (1) · Bilal Fawaz, MD (1) · Christopher Zachary, MBBS FRCP (1) · David M. Pariser, MD (1) · David Wilson, MD (1) · Edward Lain, MD, MBA (1) · Eric Berg, MD (1) · Jacqueline Morley (1) · Jim Lee, Dr. (1) · Keyvan Nouri, MD (1) · Lior Rosenberg, Prof. (1) · Sari Koskenmies, Head of Department (1)